Cytosorbents Corporation reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was USD 9.79 million compared to USD 9.45 million a year ago. Net loss was USD 6.36 million compared to USD 7.33 million a year ago.

Basic loss per share from continuing operations was USD 0.12 compared to USD 0.17 a year ago. Diluted loss per share from continuing operations was USD 0.12 compared to USD 0.17 a year ago.